List specific goals of treatment for Maria.

In the case of Maria, primary hypothyroidism is a medical condition where the thyroid gland does not produce enough hormones. Treatment for this condition includes hormone replacement therapy with synthetic thyroid hormones. The goal of this treatment should be to restore normal thyroid hormone levels in the body, reduce signs and symptoms, and minimize the risk of long-term complications (Bilous et al., 2021). The doctor should aim to monitor her progress to assess how well the treatment is working. This can be done by regularly checking her blood work for any changes in hormone levels. She may need to adjust her dosage to achieve the desired results if needed.

The doctor should also assess Maria regularly to ensure the treatment is effective and to spot any side effects. While treating Maria, it is important to provide her with emotional support and education. She should be aware of the signs and symptoms of hypothyroidism and be able to recognize any changes in her health (Bilous et al., 2021). With the right support, Maria can make lifestyle changes that can be beneficial in optimizing her treatment outcomes.

What drug therapy would you prescribe? Why?

In the case of Maria, a 29-year-old woman with a seven-month history of heavy, irregular menses, weight gain, constipation, and decreased energy, I would recommend levothyroxine, a synthetic form of the hormone thyroxine, to treat her primary hypothyroidism. This hormone helps regulate metabolism, energy, and body temperature and is the most commonly prescribed drug for patients with this condition. The dosage, frequency, and duration of the drug therapy depend on the degree of the patient’s hypothyroidism and their individual needs; however, I would typically prescribe a daily dosage of 25-50 mcg. This dosage can then be increased gradually until the desired level is achieved. Depending on the patient’s individual needs, the frequency and duration of the drug therapy may need to be adjusted. Always monitor the patient’s TSH and T4 levels regularly to ensure the dosage is effective (Effraimidis et al., 2021). In summary, to treat Maria’s primary hypothyroidism, I would prescribe levothyroxine, with a starting daily dosage of 25-50 mcg, and adjust the dosage, frequency, and duration as required. Regular monitoring is also vital for ensuring the effectiveness of the medication.

What are the parameters for monitoring the success of the therapy?

Once a diagnosis of primary hypothyroidism is made, it is important to monitor the patient’s progress with therapy. The most reliable way to monitor the success of therapy is to regularly measure the patient’s Free T4, Thyroid Stimulating Hormone (TSH) level, and thyroid peroxidase (anti-TPO) antibodies. Additionally, indicators such as symptoms, body weight, blood pressure, physical examination, and electrolyte levels should be monitored to help determine if the patient is responding to treatment. In Maria’s case, it is important to monitor her Free T4, TSH, and anti-TPO antibody levels to ensure they return to normal levels (Fitzgerald & Falhammar, 2022). Her progress should also be monitored via physical examination, weight, and blood pressure. The patient should also be evaluated for other thyroid-related conditions, such as thyroid nodules or Graves’ Disease, as these can significantly impact the success of treatment. Furthermore, any changes in symptoms, such as an increase in energy levels or a decrease in menstrual problems, should also be monitored as indicators of success with therapy.

Discuss specific patient education based on the prescribed therapy.

Given Maria’s diagnosis of primary hypothyroidism, it is important for her to be provided with adequate patient education regarding the prescribed levothyroxine therapy. Patient education typically involves providing Maria with information about her condition and medications. As such, it is important to stress the importance of taking the prescribed levothyroxine to achieve and maintain optimal health. Additionally, Maria should be informed of the potential side effects of the medication, as well as any signs and symptoms that could indicate that a change in dosage or additional medical attention is necessary (Jonklaas et al., 2021). Additionally, patient education should include an explanation of the importance of taking the medication regularly and at the same time of day each day to ensure optimal absorption of the medication. Additionally, Maria should be encouraged to avoid taking food or supplements containing iron or calcium within four hours of taking the levothyroxine, as this can interfere with the absorption of the medication. Furthermore, it is important to discuss follow-up plans with Maria to assess the medication’s effectiveness and make any necessary adjustments or changes.

List one or two adverse reactions for the selected agent that would cause you to change therapy.

In the case of Maria, who has primary hypothyroidism, it is essential to monitor the treatment with levothyroxine carefully. Side effects of levothyroxine can include insomnia, nervousness, appetite changes, and an irregular heartbeat (Jonklaas et al., 2021). If Maria were to experience any adverse reactions, it might be necessary to change the therapy prescribed. Therefore, in the case of an elevated heart rate, severe insomnia, or drastic changes in appetite, it would be wise to switch to an alternative thyroid hormone medication or to adjust the dosage of levothyroxine being taken.

What would be the choice for second-line therapy?

The second-line therapy choice for primary hypothyroidism, when treatment with levothyroxine is insufficient, is liothyronine. Liothyronine is a medication that acts as a synthetic form of the thyroid hormone triiodothyronine (T3). The usual dosage is 5-20 mcg/day orally, which can be adjusted depending on the patient’s response and levels of the thyroid hormones. It is recommended to take the medication once a day and to reassess TSH, free T4, and free T3 concentrations after six weeks (Concepción-Zavaleta et al., 2021). If the new tests reveal that the patient is still symptomatic, treatment can be further adjusted. Liothyronine should be taken for no more than 2-3 months. It is important to monitor TSH and thyroid hormone levels throughout treatment to determine which therapy is the most effective for each individual.

What over-the-counter and alternative medications would be appropriate for Maria?

Over-the-counter medications such as multivitamins, probiotics, and omega-3 fatty acids may help to ameliorate some of the symptoms of primary hypothyroidism. Multivitamins should be taken at the recommended dosage of one pill per day. Probiotics can be taken in one capsule daily, while omega-3 fatty acids can be taken at 1-2 tablespoons daily (Concepción-Zavaleta et al., 2021). Alternative treatments such as acupuncture may also help improve primary hypothyroidism symptoms. Acupuncture should be done for at least ten sessions over 4-6 weeks. It is important to consult a healthcare professional before beginning any alternative treatment.

What lifestyle changes would you recommend to Maria?

In light of Maria’s diagnosis of primary hypothyroidism, it is important to recommend the lifestyle changes necessary to help manage the condition. In particular, Maria should focus on changes to her diet, exercise habits, and stress levels. First and foremost, it is important to ensure that Maria has a balanced and healthy diet (Mahdavi et al., 2021). Consuming foods high in nutrients, vitamins, and minerals can help her maintain a healthy weight, boost her immunity, and improve overall energy levels, which the condition may hamper. Additionally, it is important to be mindful of Maria’s current iron and calcium supplement intake, opting for food sources of these important minerals instead.

In terms of exercise, Maria should talk to her healthcare provider to establish a tailored exercise plan to help her maintain a healthy weight and increase her energy levels. Since primary hypothyroidism can cause tiredness, fatigue, and malaise, the exercise plan should be reasonable. Rather, it should consist of low-impact aerobic exercises, such as swimming and walking, to boost her energy without taking too much from her (Mahdavi et al., 2021). Finally, Maria should take steps to reduce her stress levels. This often requires lifestyle changes, such as simplifying one’s life and focusing on activities that bring joy and relaxation. Mindfulness practices such as yoga, tai chi, and meditation can also help to reduce stress. Additionally, Maria needs to get proper rest to help her body cope with the condition’s symptoms.

Describe one or two drug–or drug–food interactions for the selected agent.

Patients taking levothyroxine are advised to avoid eating soy products, fiber-containing foods, and calcium supplements within four hours of taking the medication, as these could interfere with the drug’s absorption. One drug-drug interaction to consider is when levothyroxine is taken in combination with carbamazepine, as this can reduce the effectiveness of levothyroxine (Mahdavi et al., 2021). When taking levothyroxine, patients should also be mindful of interactions with other medications, such as antacids, antidepressant medications, and anticoagulants. They should discuss any potential interactions with their healthcare provider. In addition, alcohol consumption should be monitored while taking levothyroxine, as it can enhance the side effects of the drug, such as nervousness, insomnia, and a rapid heart rate (Effraimidis et al., 2021). Alcohol consumption has also been linked to reduced levels of thyroid hormones in the body and should be avoided if possible. Overall, patients should speak with their healthcare provider about any potential interactions and follow the specific dosing instructions for optimal dosing and absorption of the medication.

 

References

Bilous, I., Pavlovych, L., & Kamyshnyi, A. (2021). Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in patients’ blood. Endocrine Regulations, 55(1), 5–15. https://doi.org/10.2478/enr-2021-0002

Concepción-Zavaleta, M. J., Ildefonso-Najarro, S. P., Paz-Ibarra, J., Fernández-Dávila, F. R. V., Gómez-Condori, D. C. D., Rivera-Fabián, K. E., Herrera-Cabezas, R. G., & Concepción-Urteaga, L. A. (2021). Liothyronine use in primary hypothyroidism — current concepts. Endokrynologia Polska, 72(6), 650–660. https://doi.org/10.5603/ep.a2021.0093

Effraimidis, G., Watt, T., & Feldt-Rasmussen, U. (2021). Levothyroxine Therapy in Elderly Patients with Hypothyroidism. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.641560

Fitzgerald, S. A., & Falhammar, H. (2022, June 16). Redefinition of Successful Treatment of Patients with Hypothyroidism. Is TSH the Best Biomarker of Euthyroidism? Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.920854

Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., Watt, T., & Dayan, C. M. (2021). Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. Thyroid, 31(2), 156–182. https://doi.org/10.1089/thy.2020.0720

Mahdavi, M., Amouzegar, A., Mehran, L., Madreseh, E., Tohidi, M., & Azizi, F. (2021). Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study. BMC Endocrine Disorders, 21(1). https://doi.org/10.1186/s12902-021-00743-4

CLICK HERE TO ORDER A PLAGIARISM-FREE PAPER

NU641 Case Study Week 14: Thyroid Disorders

Write four pages Each

Provide 6 or more references for both papers. 

Jessica wants her’s to look more like PV3 and Airen’s. Jessica wants four pages.

Pay Attention: For question 2 and 6. When mentioning a drug. Provide the dosage, frequency and duration. Just as Airen mentioned. The same is done in PV2 and PV1 question 2.

For Robert, Also focus on PV3 and other samples. Make sure to provide the dosage, frequency and duration for question 2 and 6. Please do not use the 5mcg in PV2 for Robert. I think it is too small.

NU641 Case Study Week 14 – Thyroid Disorders

 

Maria is a 29-year-old woman with a seven-month history of heavy, irregular menses, a 5-lb weight gain, constipation, and decreased energy. Her past history is unremarkable. She takes no prescription medications but uses iron and calcium supplements. She has a family history of thyroid disease. On examination, her weight is 152 lbs, her heart rate is 64 bpm, and her blood pressure is 138/86. Her thyroid gland is mildly enlarged, without nodularity. She has trace edema in her lower extremities, and her reflexes are slow.

 

Laboratory studies are as follows:

 

TSH is 15.3 mIU/mL (elevated), free T4 is 0.3 mIU/mL (decreased), and total cholesterol is 276 mg/mL.

 

Diagnosis: Primary Hypothyroidism

1. List specific goals of treatment for Maria.
2. What drug therapy would you prescribe? Why?
3. What are the parameters for monitoring the success of the therapy?
4. Discuss specific patient education based on the prescribed therapy.
5. List one or two adverse reactions for the selected agent that would cause you to change therapy.
6. What would be the choice for second-line therapy?
7. What over-the-counter and/or alternative medications would be appropriate for Maria?
8. What lifestyle changes would you recommend to Maria?
9. Describe one or two drug–drug or drug–food interactions for the selected agent.